DERMEND Trademark

Trademark Overview


On Monday, January 17, 2022, a trademark application was filed for DERMEND with the United States Patent and Trademark Office. The USPTO has given the DERMEND trademark a serial number of 97223030. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 28, 2023. This trademark is owned by Vivex Biologics Group, Inc.. The DERMEND trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft tissue
dermend

General Information


Serial Number97223030
Word MarkDERMEND
Filing DateMonday, January 17, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 28, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 29, 2022

Trademark Statements


Goods and ServicesHuman allograft tissue

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 24, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVivex Biologics Group, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339

Party NameVivex Biologics Group, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339

Trademark Events


Event DateEvent Description
Monday, August 28, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 28, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 24, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 25, 2022ASSIGNED TO EXAMINER
Monday, January 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 20, 2022NEW APPLICATION ENTERED

Related Keywords


dermend tissue allograft human